References in periodicals archive ?
As a gauge of patients' response to therapy, serial UPEP studies combined with densitometric scanning are commonly used to measure changes in Bence Jones protein excretion over time.
CT and measurements of serum immunoglobulin and urinary Bence Jones protein levels may be useful in detecting recurrence or conversion to multiple myeloma.
Findings on bone marrow biopsy were normal, as were the results of immunologic laboratory analysis, including an assay of Bence Jones proteins.
The first laboratory test for a protein cancer marker, the Bence Jones protein in urine, was described in 1847.
Tests for Bence Jones protein in the urine and for serum myeloma protein were negative.
Restricted electrophoretic heterogeneity of immunoglobulin light chains in urine: a cause for confusion with Bence Jones protein.
Urinary /32-microglobulin masquerading as a Bence Jones protein.
For more than 150 years, the presence of Bence Jones protein [immunoglobulin free light chains (FLCs)] in the urine has been an important diagnostic marker for multiple myeloma.
2]-microglobulin, quantitative immunoglobulins, and Bence Jones proteins in the urine.